Paranasal sinus carcinoma
MONDO:0000380A malignant epithelial neoplasm arising in the paranasal sinus.
Also known as: malignant neoplasm of paranasal sinus, malignant paranasal sinus neoplasm, paranasal sinus cancer, accessory sinus cancer, accessory sinus carcinoma, cancer of paranasal sinus, carcinoma of accessory sinus, carcinoma of paranasal sinus
2867 clinical trials for this condition and its sub-types, 4 tagged with Paranasal sinus carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Paranasal sinus carcinoma
-
Paranasal sinus squamous cell carcinoma 11 trials
4 sub-types
- Maxillary sinus squamous cell carcinoma 1 trial
- Ethmoid sinus squamous cell carcinoma 0 trials
- Frontal sinus squamous cell carcinoma 0 trials
- Sphenoid sinus squamous cell carcinoma 0 trials
-
2 sub-types
-
Maxillary sinus carcinoma 1 trial · 2 incl. sub-types
3 sub-types
- Maxillary sinus squamous cell carcinoma 1 trial
- Maxillary sinus adenocarcinoma 0 trials
- Maxillary sinus adenoid cystic carcinoma 0 trials
-
Ethmoid sinus cancer 0 trials
3 sub-types
- Ethmoid sinus adenocarcinoma 0 trials
- Ethmoid sinus adenoid cystic carcinoma 0 trials
- Ethmoid sinus squamous cell carcinoma 0 trials
-
Frontal sinus cancer 0 trials
1 sub-type
-
Paranasal sinus sarcoma 0 trials
-
Sphenoidal sinus cancer 0 trials
1 sub-type
-
New radiation approach aims to spare healthy tissue in sinus cancer treatment
Disease control Recruiting nowThis Phase 2 trial tests a new way to give radiation for sinus cancer after endoscopic surgery. Instead of radiating the whole sinus area, doctors will use a 'dose painting' technique that targets only the areas where cancer was found. The goal is to see if this reduces side effe…
Phase 2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Common pain gel could shield cancer patients from radiation burns
Prevention Recruiting nowThis study tests whether a gel containing diclofenac, a common anti-inflammatory drug, can prevent severe skin irritation caused by radiation therapy. About 156 adults with head/neck or breast cancer will apply the gel or a placebo to the treated skin three times daily during the…
Sponsor: The Second Affiliated Hospital of Hainan Medical University • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC